{"id":41894,"date":"2021-12-20T07:35:15","date_gmt":"2021-12-20T07:35:15","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=41894"},"modified":"2021-12-21T09:51:46","modified_gmt":"2021-12-21T09:51:46","slug":"reducing-the-risk-of-covid-19-in-research-studies-that-involve-interrupting-art","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/41894","title":{"rendered":"Reducing the risk of COVID-19 in research that involves interrupting ART"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><strong>Simon Collins, HIV i-Base<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\">These two papers, published as letters in JAIDS, discuss ways to reduce risks to participants in cure-related studies that involve a treatment interruption. <\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Some earlier studies were rightly put on hold during the early pandemic but wider availability of vaccines have enabled many of these studies to now reopen.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBreferences\"><span lang=\"EN-US\">References<\/span><\/p>\n<\/div>\n<div>\n<ol>\n<li class=\"HTBreferences\"><span lang=\"EN-US\">Peluso ML et al. SARS-CoV-2 booster vaccination for participants in \u201cHIV cure\u201d-related clinical trials. JAIDS. Letter. doi: 10.1097\/QAI.0000000000002875. (26 November 2021).<br \/>\n<\/span><a href=\"https:\/\/journals.lww.com\/jaids\/Citation\/9000\/SARS_CoV_2_booster_vaccination_for_participants_in.95756.aspx\">https:\/\/journals.lww.com\/jaids\/Citation\/9000\/SARS_CoV_2_booster_vaccination_for_participants_in.95756.aspx<\/a><\/li>\n<li class=\"HTBreferences\">Peluso ML et al. SARS-CoV-2 Vaccination in the context of ongoing HIV cure-related research studies. JAIDS JAIDS. Letter, 87(4)e232-e233. doi: 10.1097\/QAI.0000000000002690. (1 August 2021).<br \/>\n<a href=\"https:\/\/journals.lww.com\/jaids\/Fulltext\/2021\/08010\/SARS_CoV_2_Vaccination_in_the_Context_of_Ongoing.13.aspx\">https:\/\/journals.lww.com\/jaids\/Fulltext\/2021\/08010\/SARS_CoV_2_Vaccination_in_the_Context_of_Ongoing.13.aspx<\/a><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base These two papers, published as letters in JAIDS, discuss ways to reduce risks to participants in cure-related studies that involve a treatment interruption. Some earlier studies were rightly put on hold during the early pandemic but &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,278],"tags":[],"class_list":["post-41894","post","type-post","status-publish","format-standard","hentry","category-cure-research","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=41894"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41894\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=41894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=41894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=41894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}